TP53 and cancer: To reveal protein and RNA populations controlled by oncogenes – mutant TP53, mutant KRAS, and MYC – we used CRISPR-Cas9-mediated editing to downregulate their expression levels in a panel of cell lines derived from cancer types frequently driven by the mentioned oncogenes (Fig. 1A).